Pro Health Tips
Wednesday, 21 February 2018
Durvalumab Clears Phase II Trial With Positive Anti-tumor Activity
CONDOR Phase-2 trial of durvalumab shows encouraging anti-tumor activity as second-line treatment in recurrent/metastatic head and neck cancer tumors.
from Medindia Health News http://ift.tt/2ogPoji
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
CONDOR Phase-2 trial of durvalumab shows encouraging anti-tumor activity as second-line treatment in recurrent/metastatic head and neck cancer tumors.
No comments:
Post a Comment